Feasibility of daily concurrent chemoradiation therapy as nonsurgical management for esophageal cancer: Our experience and theoretical background

Journal of Surgical Oncology

Volumn 74, Issue 2, 2000, Pages 134-137

  Shimoyama, Shouji ^a   Aoki, Fumio ^a   Murakami, Toshikazu ^a   Toyoda, Kenji ^a   Kaminishi, Michio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

5 fluorouracil; Biochemical modulation; Chemoradiation therapy; Cisplatin; Esophageal cancer; Radiosensitizing effect

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DYSPHAGIA; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIOSENSITIZATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 0033946573     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9098(200006)74:2<134::AID-JSO10>3.0.CO;2-2     Document Type: Article

References (26)

1. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1996. CA Cancer J Clin 1996;65:5-27.
2. Launois B, Delarue D, Campion JP, et al. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981;153:690-692.
3. Ténière P, Hay J-M, Fingerhut A, et al. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 1991;173:123-130.
4. Japanese Esophageal Oncology Group. A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Chest 1993;104:203-207.
5. Schlag PM. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 1992;127: 1446-1450.
6. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-1784.
7. Richmond J, Seydel HG, Bae Y, et al. Comparison of three treatment strategies for esophageal cancer within a single institution. Int J Radiat Oncol Biol Phys 1987;13:1617-1620.
8. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326: 1593-1598.
9. Tsujinaka T, Shiozaki H, Kido Y, et al. Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy for inoperable squamous cell carcinoma of the esophagus potentially followed by surgery. J Surg Oncol 1995:;58:50-56.
10. Scanlon KJ, Safirstein RL, Thies H, et al. Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells. Cancer Res 1983;43:4211-4215.
11. Shirasaka T, Shimamoto Y, Ohshimo H, et al. Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Cancer Chemother Pharmacol 1993;32:167-172.
12. Scanlon KJ, Newman EM, Lu Y, et al. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 1986;83:8923-8925.
13. Fraile RJ, Baker LH, Buroker TR, et al. Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. Cancer Res 1980;40:2223-2228.
14. Lokich JJ, Ahlgren JD, Gullo JJ, et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. J Clin Oncol 1989;7:425-432.
15. Chung Y-S, Yamashita Y, Inoue T, et al. Contiuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma. Cancer 1997;80: 1-7.
16. Nakajima Y, Miyamoto T, Tanabe M, et al. Enhancement of mammalian cell killing by 5-fluorouracil in combination with X-rays. Cancer Res 1979;39:3763-3767.
17. Smalley SR, Kimler BF, Evans RG. 5-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cells. Int J Radiat Oncol Biol Phys 1991;20:207-211.
18. Tanabe M, Godat D, Kallman RF. Effects of fractionated schedules of irradiation combined with cis-diamminedichloroplatinum II on the SCCVII/ST tumor and normal tissues of the C3H /KM mouse. Int J Radiat Oncol Biol Phys 1987;13:1523-1532.
19. Sun J-R, Brown JM. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Radiat Res 1993;133:252-256.
20. Schaake-Koning C, Van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992;326:524-530.
21. Keyomarsi K, Moran RG. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells. Cancer Res 1986;46:5229-5235.
22. Shimoyama S, Aoki F, Kojima J, Kaminishi M. A case of complete response to esophageal cancer by a novel concurrent chemoradiation therapy. Hepatogastroenterology 1999;46:2409-2413.
23. Sobin LH, Wittekind C, editors. TNM classification of malignant tumours. New York: Wiley-Liss; 1997:54-58.
24. Shimoyama S, Konishi T, Kawahara M, et al. Pre-operative chemoradiation therapy with 5-fluorouracil and low-dose daily cisplatin for esophageal cancer: a preliminary report. Jpn J Clin Oncol 1999:;29:132-136.
25. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981;47:207-214.
26. Shimoyama S, Konishi T, Kawahara M, et al. Complete response of esophageal cancer achieved by combination therapy with 5-fluorouracil, low-dose cisplatin, and radiation: report of a case. Surg Today 1998;28:1163-1167.